what is a microdose glp-1 Microdosing Safety Information forProactive HealthMicrodose GLP-1Rx

DOI.org (Crossref) , Afrin, Lawrence B., et al

Published online January 29, 2024:e076410

Monotherapy with the once weekly GLP-1 receptor agonist dulaglutide for 12 weeks in Japanese patients with type 2 diabetes: dose-dependent effects on glycaemic control in a randomised, double-blind, placebo-controlled study

The Bottom Line The most accurate GLP-1 side effects timeline is not a straight line from "sick in week 1" to "fully adjusted by month 3." Digestive symptoms are common early and during dose escalation

I love who I amand I always have

With their widespread availability and increasing popularity, one key question remains: who should receive GLP-1 drugs